Difgen Pharmaceuticals Acquires Aveva Drug Delivery Services Inc; Strengthens Its Position In Offering Difficult And Differentiated Pharmaceuticals Dosage Forms With A Us-Based Development And Manufacturing Capability

Apr 24, 2023•over 2 years ago

Acquiring Company

DifGen

Acquired Company

Aveva

TamaracManufacturingBiotechnologyManufacturing

Description

DifGen Pharmaceuticals LLC ("DifGen") announced today that it has acquired Aveva Drug Delivery Services Inc. ("Aveva") a fully integrated developer and manufacturer of Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF).

Company Information

Company

DifGen

Location

Tamarac, Florida, United States

About

The FDA-registered manufacturing facility located in Tamarac, Florida has state-of the art manufacturing capability to handle solutions/ suspension/ emulsions through blow-fill-seal, form fill seal technology and traditional filling of liquid and semi-solid products in a variety of dosage forms including stick packs and unit-dose cups.

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Difgen Pharmaceuticals Acquires Aveva Drug Delivery Services Inc; Strengthens Its Position In Offering Difficult And Differentiated Pharmaceuticals Dosage Forms With A Us-Based Development And Manufacturing Capability

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

M&A Insights

Company Information